The Benefits of Prebiotics and Probiotics on Mental Health

被引:10
作者
Bistas, Karlyle G. [1 ]
Tabet, Jean Paul [2 ]
机构
[1] Wayne State Univ, Detroit Med Ctr, Psychiat & Behav Sci, Detroit, MI 48202 USA
[2] Med Univ Amer, Sch Med, Charlestown, St Kitts & Nevi
关键词
gut microflora; depression; anxiety; probiotics; prebiotics; DOUBLE-BLIND; GUT MICROBIOTA; DEPRESSION; SYMPTOMS; STRESS; BRAIN;
D O I
10.7759/cureus.43217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In individuals with depression and anxiety, the composition or alteration of their gut microbiota can significantly affect their psychological symptoms. Articles for this study were selected using PubMed and NCBI (National Center for Biotechnology Information) with the following search terms: "gut microbiota," "depression," "anxiety," "probiotics," and "prebiotics." These studies evaluated the composition of the gut microbiota and the decrease in symptoms of depression and anxiety due to treatment with probiotics and prebiotics. Only papers published after 2015 were included. There was a significant relationship between the composition and alteration of the gut microbiota and the presence or variation of symptoms of depression and anxiety. Treatment with probiotics or prebiotics improved the symptoms of these mental health conditions. This literature review examines how different prebiotics and probiotics affect mental health and how altering individuals' gut microbiota correlates with depression and anxiety. Treatment with probiotics or prebiotics may decrease the severity of these mental disorders by altering the gut microbiota.
引用
收藏
页数:10
相关论文
共 34 条
  • [1] Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies
    Abdul-Aziz, Muslihudeen A.
    Cooper, Alan
    Weyrich, Laura S.
    [J]. FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [2] Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats
    Ait-Belgnaoui, Afifa
    Durand, Henri
    Cartier, Christel
    Chaumaz, Gilles
    Eutamene, Helene
    Ferrier, Laurent
    Houdeau, Eric
    Fioramonti, Jean
    Bueno, Lionel
    Theodorou, Vassilia
    [J]. PSYCHONEUROENDOCRINOLOGY, 2012, 37 (11) : 1885 - 1895
  • [3] Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial
    Akkasheh, Ghodarz
    Kashani-Poor, Zahra
    Tajabadi-Ebrahimi, Maryam
    Jafari, Parvaneh
    Akbari, Hossein
    Taghizadeh, Mohsen
    Memarzadeh, Mohammad Reza
    Asemi, Zatollah
    Esmaillzadeh, Ahmad
    [J]. NUTRITION, 2016, 32 (03) : 315 - 320
  • [4] [Anonymous], 2020, LANCET GLOB HEALTH, V8, pE1352, DOI 10.1016/S2214-109X(20)30432-0
  • [5] [Anonymous], 2022, Depression
  • [6] Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study
    Azpiroz, F.
    Dubray, C.
    Bernalier-Donadille, A.
    Cardot, J-M
    Accarino, A.
    Serra, J.
    Wagner, A.
    Respondek, F.
    Dapoigny, M.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2017, 29 (02)
  • [7] Beck Depression Inventory (BDI), 2022, US
  • [8] Sex differences in gut microbiota in patients with major depressive disorder
    Chen, Jian-jun
    Zheng, Peng
    Liu, Yi-yun
    Zhong, Xiao-gang
    Wang, Hai-yang
    Guo, Yu-jie
    Xie, Peng
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 647 - 655
  • [9] Clapp M, 2017, CLINICS PRACT, V7, P131, DOI 10.4081/cp.2017.987
  • [10] Evidences of a New Psychobiotic Formulation on Body Composition and Anxiety
    Colica, Carmela
    Avolio, Ennio
    Bollero, Patrizio
    de Miranda, Renata Costa
    Ferraro, Simona
    Salimei, Paola Sinibaldi
    De Lorenzo, Antonino
    Di Renzo, Laura
    [J]. MEDIATORS OF INFLAMMATION, 2017, 2017